Qsemble Capital Management, LP Bristol Myers Squibb CO Transaction History
Qsemble Capital Management, LP
- $1.02 Trillion
- Q3 2025
A detailed history of Qsemble Capital Management, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Qsemble Capital Management, LP holds 235,945 shares of BMY stock, worth $11 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
235,945
Previous 120,939
95.09%
Holding current value
$11 Million
Previous $5.6 Billion
90.08%
% of portfolio
1.04%
Previous 0.54%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,688Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...